| Trial ID: | L0609 |
| Source ID: | NCT05544513
|
| Associated Drug: |
Ferrous Sulfate 3 Days Week
|
| Title: |
Oral Iron Supplementation for Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Disease|Iron-Deficiency Anemia|Anemia of Chronic Kidney Disease|Dysbiosis
|
| Interventions: |
DRUG: Ferrous sulfate 3 days week|DRUG: Ferrous sulfate daily|DRUG: Ferrous sulfate higher concentration
|
| Outcome Measures: |
Primary: Change in cytokines plasma levels measured by ELISA after supplementation with oral iron, cytokines plasma levels, 2 months | Secondary: Change in uremic toxin plasma levels after supplementation with oral iron, Get blood samples to evaluate the supplementation effects in uremic toxins such as indoxyl sulfate, p-cresyl sulfate, 2 months
|
| Sponsor/Collaborators: |
Sponsor: Universidade Federal Fluminense
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
6
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2022-08-01
|
| Completion Date: |
2026-12-30
|
| Results First Posted: |
|
| Last Update Posted: |
2025-04-03
|
| Locations: |
Denise Mafra, Rio de Janeiro, RJ, 22260050, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT05544513
|
